162 related articles for article (PubMed ID: 22815786)
21. Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells.
Baetta R; Donetti E; Comparato C; Calore M; Rossi A; Teruzzi C; Paoletti R; Fumagalli R; Soma MR
Pharmacol Res; 1997 Aug; 36(2):115-21. PubMed ID: 9344639
[TBL] [Abstract][Full Text] [Related]
22. Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.
Pierno S; Camerino GM; Cippone V; Rolland JF; Desaphy JF; De Luca A; Liantonio A; Bianco G; Kunic JD; George AL; Conte Camerino D
Br J Pharmacol; 2009 Apr; 156(8):1206-15. PubMed ID: 19220292
[TBL] [Abstract][Full Text] [Related]
23. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry.
Yasuda N; Matzno S; Iwano C; Nishikata M; Matsuyama K
J Pharm Biomed Anal; 2005 Sep; 39(3-4):712-7. PubMed ID: 15927433
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
Buttmann M; Lorenz A; Weishaupt A; Rieckmann P
J Neurochem; 2007 Aug; 102(4):1001-8. PubMed ID: 17442054
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of HMG-CoA reductase inhibitors on fibrinogen.
Rosenson RS; Tangney CC; Schaefer EJ
Atherosclerosis; 2001 Apr; 155(2):463-6. PubMed ID: 11254918
[TBL] [Abstract][Full Text] [Related]
27. Effect of statins on fibroblasts from human nasal polyps and turbinates.
Folli C; Descalzi D; Bertolini S; Riccio AM; Scordamaglia F; Gamalero C; Barbieri M; Passalacqua G; Canonica GW
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):84-9. PubMed ID: 19334372
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug.
Hagiwara M; Kataoka K; Arimochi H; Kuwahara T; Nakayama H; Ohnishi Y
World J Gastroenterol; 2005 Feb; 11(7):1040-3. PubMed ID: 15742411
[TBL] [Abstract][Full Text] [Related]
29. Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation.
Sassano A; Altman JK; Gordon LI; Platanias LC
Leuk Lymphoma; 2012 Sep; 53(9):1779-84. PubMed ID: 22356114
[TBL] [Abstract][Full Text] [Related]
30. Differences between statins on clinical endpoints: a population-based cohort study.
Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
[TBL] [Abstract][Full Text] [Related]
31. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
32. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
33. Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs.
Satoh K; Ichihara K
J Cardiovasc Pharmacol; 2000 Feb; 35(2):256-62. PubMed ID: 10672858
[TBL] [Abstract][Full Text] [Related]
34. Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Nishiyama Y; Ueda M; Otsuka T; Katsura K; Abe A; Nagayama H; Katayama Y
J Atheroscler Thromb; 2011; 18(2):131-7. PubMed ID: 21081834
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.
Knapp AC; Huang J; Starling G; Kiener PA
Atherosclerosis; 2000 Sep; 152(1):217-27. PubMed ID: 10996358
[TBL] [Abstract][Full Text] [Related]
36. Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells.
Sekiya A; Morishita E; Maruyama K; Torishima H; Ohtake S
J Atheroscler Thromb; 2015 Jul; 22(7):660-8. PubMed ID: 25735397
[TBL] [Abstract][Full Text] [Related]
37. Critical promoter region for statin-induced human endothelial nitric oxide synthase (eNOS) transcription in EA.hy926 cells.
Mashimo Y; Ishikawa T; Numakura M; Kinoshita M; Teramoto T
J Atheroscler Thromb; 2013; 20(4):321-9. PubMed ID: 23258079
[TBL] [Abstract][Full Text] [Related]
38. Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures.
Loppnow H; Zhang L; Buerke M; Lautenschläger M; Chen L; Frister A; Schlitt A; Luther T; Song N; Hofmann B; Rose-John S; Silber RE; Müller-Werdan U; Werdan K
J Cell Mol Med; 2011 Apr; 15(4):994-1004. PubMed ID: 20158569
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin sensitises vascular smooth muscle cells, but not endothelial cells, to TNF-α-induced cell death.
Giordano A; Romano S; Nappo G; Messina S; Polimeno M; Corcione N; Cali G; Ferraro P; Monaco M; Zambrano N; Romano MF
Curr Pharm Des; 2012; 18(38):6331-8. PubMed ID: 23092297
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin counteracts high glucose-induced Krüppel-like factor 2 suppression in human umbilical vein endothelial cells.
Liu YS; Xu DL; Huang ZW; Hao L; Wang X; Lu QH
Postgrad Med; 2015 Jun; 127(5):446-54. PubMed ID: 25927862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
